Trial Outcomes & Findings for Measurement of Bispectral Index and Awareness in Patients Undergoing Electrophysiology Studies With Isoproterenol (NCT NCT01377636)
NCT ID: NCT01377636
Last Updated: 2015-02-23
Results Overview
Increasing doses of isoproterenol (5,10,15,20 mcg/minute) were administered to patients undergoing catheter ablation for atrial fibrillation. BIS levels were measured continuously before and after isoproterenol administration. Number of participants with increase in BIS reading during anesthetic steady state are reported below. The BIS scale ranges from 0 to 100. The individual's baseline BIS was measured continuously and was maintained in an anesthetic steady state with minimum variance prior to isoproterenol. A deviation from the mean in excess of 3 points (2 STD) was defined categorically as a positive response and was counted dichotomously.
COMPLETED
NA
20 participants
During time of Electrophysiology (EP) studies.
2015-02-23
Participant Flow
During the preoperative evaluation for anesthesia, the patients scheduled for catheter ablation for atrial fibrillation were approached by the research associate for informed consent and enrollment into the study. The research consent was separate from the clinical anesthesia and procedural consents.
Participant milestones
| Measure |
Pre and Post Isoproterenol Infusion
Bispectral EEG (BIS) monitoring and neurological examinations were repeated throughout an isoproterenol infusion protocol (20 minutes maximum) to measure the changes in arousal and ability to follow commands under anesthesia
|
|---|---|
|
Overall Study
STARTED
|
20
|
|
Overall Study
COMPLETED
|
20
|
|
Overall Study
NOT COMPLETED
|
0
|
Reasons for withdrawal
Withdrawal data not reported
Baseline Characteristics
Measurement of Bispectral Index and Awareness in Patients Undergoing Electrophysiology Studies With Isoproterenol
Baseline characteristics by cohort
| Measure |
Pre and Post Isoproterenol Infusion
n=20 Participants
Subjects undergoing catheter ablation for atrial fibrillation had measurements pre and post isoproterenol infusion
|
|---|---|
|
Age, Categorical
<=18 years
|
0 Participants
n=99 Participants
|
|
Age, Categorical
Between 18 and 65 years
|
11 Participants
n=99 Participants
|
|
Age, Categorical
>=65 years
|
9 Participants
n=99 Participants
|
|
Age, Continuous
|
62 years
STANDARD_DEVIATION 8.2 • n=99 Participants
|
|
Sex: Female, Male
Female
|
5 Participants
n=99 Participants
|
|
Sex: Female, Male
Male
|
15 Participants
n=99 Participants
|
|
Region of Enrollment
United States
|
20 participants
n=99 Participants
|
PRIMARY outcome
Timeframe: During time of Electrophysiology (EP) studies.Increasing doses of isoproterenol (5,10,15,20 mcg/minute) were administered to patients undergoing catheter ablation for atrial fibrillation. BIS levels were measured continuously before and after isoproterenol administration. Number of participants with increase in BIS reading during anesthetic steady state are reported below. The BIS scale ranges from 0 to 100. The individual's baseline BIS was measured continuously and was maintained in an anesthetic steady state with minimum variance prior to isoproterenol. A deviation from the mean in excess of 3 points (2 STD) was defined categorically as a positive response and was counted dichotomously.
Outcome measures
| Measure |
Pre and Post Isoproterenol Infusion
n=20 Participants
BIS monitoring and neurological examinations were repeated throughout an isoproterenol infusion protocol (20 minutes maximum) to measure the changes in arousal and ability to follow commands under anesthesia
|
|---|---|
|
Number of Participants With an Increase in BIS Readings During Steady State
|
19 participants
|
PRIMARY outcome
Timeframe: Within 20 minutes of starting isoproterenol infusionThe BIS scale ranges from 0 to 100. The individual's baseline BIS was measured continuously and was maintained in an anesthetic steady state with minimum variance prior to isoproterenol. A deviation from the mean in excess of 3 points (2 STD) was defined categorically as a positive response and was counted dichotomously.The difference between Pre-BIS and Post-BIS was calculated.
Outcome measures
| Measure |
Pre and Post Isoproterenol Infusion
n=20 Participants
BIS monitoring and neurological examinations were repeated throughout an isoproterenol infusion protocol (20 minutes maximum) to measure the changes in arousal and ability to follow commands under anesthesia
|
|---|---|
|
BIS Change
|
24.6 units on a scale
Interval 19.3 to 29.9
|
SECONDARY outcome
Timeframe: Within 20 minutes of starting isoproterenol infusionIncreasing doses of isoproterenol (5,10,15,20 mcg/minute) were administered to patients undergoing catheter ablation for atrial fibrillation. Patients under steady state total venous anesthesia (TIVA) with propofol and remifentanil infusions with BIS around 50 normally do not move even in the absence of neuromuscular blockade. Spontaneous movement appearing like restlessness during sleep is unusual. Several patients under anesthesia after isoproterenol appear to wake up and move spontaneously.
Outcome measures
| Measure |
Pre and Post Isoproterenol Infusion
n=20 Participants
BIS monitoring and neurological examinations were repeated throughout an isoproterenol infusion protocol (20 minutes maximum) to measure the changes in arousal and ability to follow commands under anesthesia
|
|---|---|
|
Number of Participants With Spontaneous Musculoskeletal Movement
|
12 participants
|
SECONDARY outcome
Timeframe: Within 20 minutes of starting isoproterenol infusionIncreasing doses of isoproterenol (5,10,15,20 mcg/minute) were administered to patients undergoing catheter ablation for atrial fibrillation. Ability to follow verbal commands before and after isoproterenol infusion was assessed by asking subjects to "squeeze my hands".
Outcome measures
| Measure |
Pre and Post Isoproterenol Infusion
n=20 Participants
BIS monitoring and neurological examinations were repeated throughout an isoproterenol infusion protocol (20 minutes maximum) to measure the changes in arousal and ability to follow commands under anesthesia
|
|---|---|
|
Number of Participants Who Follow Verbal Command to Squeeze Hands
|
10 participants
|
OTHER_PRE_SPECIFIED outcome
Timeframe: Within 20 minutes of starting isoproterenol infusionHeart rate measured by standard EKG monitor during anesthesia. Pre- and Post Heart rates where noted. An increase of 8 percent or more was defined as a significant change in heart rate.
Outcome measures
| Measure |
Pre and Post Isoproterenol Infusion
n=20 Participants
BIS monitoring and neurological examinations were repeated throughout an isoproterenol infusion protocol (20 minutes maximum) to measure the changes in arousal and ability to follow commands under anesthesia
|
|---|---|
|
Number of Participants With Significant Change in Heart Rate
|
18 participants
|
OTHER_PRE_SPECIFIED outcome
Timeframe: Within 20 minutes of starting isoproterenol infusionNon-Invasive Blood Pressure (NIBP) is measured routinely as part of an anesthetic. Pre- and Post Blood Pressures where noted. An increase or decrease of 10 percent or more was defined as a significant change in systolic blood pressure.
Outcome measures
| Measure |
Pre and Post Isoproterenol Infusion
n=20 Participants
BIS monitoring and neurological examinations were repeated throughout an isoproterenol infusion protocol (20 minutes maximum) to measure the changes in arousal and ability to follow commands under anesthesia
|
|---|---|
|
Number of Participants With Change in Blood Pressure
|
13 participants
|
OTHER_PRE_SPECIFIED outcome
Timeframe: Within one hour of completing anesthesiaIncreasing doses of isoproterenol (5,10,15,20 mcg/minute) were administered to patients undergoing catheter ablation for atrial fibrillation. Specific pre-determined test words were spoken to the subject during administration of isoproterenol. After anesthesia, patients were tested for possible recall of those specific words. If no words were recalled, the result was categorically defined as amnesia.
Outcome measures
| Measure |
Pre and Post Isoproterenol Infusion
n=20 Participants
BIS monitoring and neurological examinations were repeated throughout an isoproterenol infusion protocol (20 minutes maximum) to measure the changes in arousal and ability to follow commands under anesthesia
|
|---|---|
|
Number of Participants With Amnesia or No Recall During Steady State
|
20 participants
|
OTHER_PRE_SPECIFIED outcome
Timeframe: Within 20 minutes of start of isoproterenolIncreasing doses of isoproterenol (5,10,15,20 mcg/minute) were administered to patients undergoing catheter ablation for atrial fibrillation after return to sinus rhythm. If a non-sinus arrhythmia resulted from the infusion, the arrhythmia was defined categorically as a positive response and was counted dichotomously.
Outcome measures
| Measure |
Pre and Post Isoproterenol Infusion
n=20 Participants
BIS monitoring and neurological examinations were repeated throughout an isoproterenol infusion protocol (20 minutes maximum) to measure the changes in arousal and ability to follow commands under anesthesia
|
|---|---|
|
Number of Participants With New Arrhythmia During Steady State.
|
4 participants
|
OTHER_PRE_SPECIFIED outcome
Timeframe: Within 20 minutes of starting isoproterenol infusionThe (ST) segment on the EKG was monitored for changes suggestive of demand ischemia. An observable EKG change compared to baseline was defined categorically as a positive response and was counted dichotomously.
Outcome measures
| Measure |
Pre and Post Isoproterenol Infusion
n=20 Participants
BIS monitoring and neurological examinations were repeated throughout an isoproterenol infusion protocol (20 minutes maximum) to measure the changes in arousal and ability to follow commands under anesthesia
|
|---|---|
|
Number of Participants Who Developed Ischemia or ST Segment Changes
|
2 participants
|
Adverse Events
Pre and Post Isoproterenol Infusion
Serious adverse events
| Measure |
Pre and Post Isoproterenol Infusion
n=20 participants at risk
In this study, serious adverse events were considered clinically significant adverse events. The well known isoproterenol effects on heart rate, rhythm, ST segments, and blood pressure were noted.
|
|---|---|
|
Cardiac disorders
Death
|
0.00%
0/20 • 24 hours
|
|
Nervous system disorders
Stroke
|
0.00%
0/20 • 24 hours
|
|
Nervous system disorders
Seizure
|
0.00%
0/20 • 24 hours
|
|
Cardiac disorders
Cardiac arrest
|
0.00%
0/20 • 24 hours
|
Other adverse events
| Measure |
Pre and Post Isoproterenol Infusion
n=20 participants at risk
In this study, serious adverse events were considered clinically significant adverse events. The well known isoproterenol effects on heart rate, rhythm, ST segments, and blood pressure were noted.
|
|---|---|
|
Cardiac disorders
Tachycardia
|
95.0%
19/20 • Number of events 19 • 24 hours
|
|
Cardiac disorders
Atrial Fibrillation/Junctional Rhythm
|
20.0%
4/20 • Number of events 4 • 24 hours
|
|
Cardiac disorders
ST Changes (transient)
|
10.0%
2/20 • Number of events 2 • 24 hours
|
|
Cardiac disorders
Hypotension
|
30.0%
6/20 • Number of events 6 • 24 hours
|
|
Cardiac disorders
Hypertension
|
30.0%
6/20 • Number of events 6 • 24 hours
|
|
Cardiac disorders
Bradycardia
|
0.00%
0/20 • 24 hours
|
|
Cardiac disorders
Ventricular arrhythmia
|
0.00%
0/20 • 24 hours
|
|
Respiratory, thoracic and mediastinal disorders
Bronchospasm
|
0.00%
0/20 • 24 hours
|
|
Respiratory, thoracic and mediastinal disorders
Pneumonia
|
0.00%
0/20 • 24 hours
|
|
Blood and lymphatic system disorders
Bleeding
|
0.00%
0/20 • 24 hours
|
|
Respiratory, thoracic and mediastinal disorders
Pulmonary embolism
|
0.00%
0/20 • 24 hours
|
Additional Information
Patrick Linton, MD, Director of Adult Off-Site Anesthesia Services
New York University Langone Medical Center, Anesthesiology
Results disclosure agreements
- Principal investigator is a sponsor employee
- Publication restrictions are in place